Nurses’ Guide to Managing Symptoms of Myeloproliferative Neoplasms
Oncology nurses discuss the importance of ongoing education on the treatments, symptoms, and available information on MPNs for patients, and oncology nurses.
Journal Review
Journal Review
Dermatology Life Quality Index Valid for Assessing Radiodermatitis in Breast Cancer Patients
A pilot study revealed the effectiveness of the DLQI in assessing quality of life measures in women with breast cancer treatment-related radiodermatitis.
Risk for VTE Persists Over the Long Term for Survivors of Childhood Cancers
These study results illustrate a need to educate survivors of childhood cancers on an ongoing potential risk for venous thromboembolism (VTE) beyond 5 years postdiagnosis.
A Call for Better Use of Personal Protective Equipment Among Nurses
A randomized trial sought to measure the effect of educational modules on nurse use of personal protection equipment when handling and/or administering chemotherapy.
Adverse Events in Randomized Clinical Trials for Targeted Therapies High in Placebo Groups
Researchers conducted a meta-analysis to determine the incidence of adverse events among patients assigned to placebo-receiving groups in randomized clinical trials.
Regular Physical Activity — Even Initiated Postdiagnosis — Improves Survival for Cancer Patients
A review of DBBR data demonstrated that regular recreational physical activity may reduce the risk of all-cause and cancer-specific mortality in persons who are habitually active as a lifestyle as well as those who adopt regular exercise as a lifestyle after diagnosis.
Safe to Administer B12 Supplementation, Pemetrexed Infusions for Lung Cancers on Same Day
Mean changes in hematologic indices found similar regardless of same-day or prior administration of B12 supplementation in patients receiving pemetrexed for NSCLC or pleural mesothelioma.
Nedaplatin Associated With Less Toxicity Than Cisplatin for MPE
In this retrospective study, researchers sought to determine the efficacy of nedaplatin vs cisplatin for the treatment of malignancy-induced malignant pleural effusion.
Managing Dermatologic Adverse Events in Patients Receiving Third-Generation EGFR-TKIs
An international team reviews osimertinib-associated dermatologic adverse events in patients treated with the third-generation EGFR-TKI.
Benefit of Chemotherapy for Breast Cancer Observed With Midrange Gene Assay Score
In a randomization of women with early-stage breast cancer, researchers explored the potential benefits of chemotherapy for women whose Oncotype DX RS was midrange.
Want to read more?
Please login or register first to view this content.